只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-06-18 2026-06-22 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 1,199 | US$146.24 | US$175,341.76 | 15,096 | SEC |
| 2026-06-18 2026-06-22 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 4,861 | US$145.43 | US$706,935.23 | 16,295 | SEC |
| 2026-06-18 2026-06-22 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 96 | US$143.90 | US$13,814.40 | 24,904 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 784 | US$138.18 | US$108,333.12 | 32,162 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 2,054 | US$137.61 | US$282,650.94 | 32,946 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 1,035 | US$145.02 | US$150,095.70 | 25,000 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 3,140 | US$139.57 | US$438,249.80 | 29,022 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 540 | US$140.58 | US$75,913.20 | 28,482 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 100 | US$141.83 | US$14,183.00 | 28,382 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 450 | US$142.20 | US$63,990.00 | 27,932 | SEC |
| 2026-06-16 2026-06-17 | BLTE BELITE BIO, INC | Scholl Hendrik Peter Officer · Chief Medical Officer | 卖出（S） | 1,897 | US$143.55 | US$272,314.35 | 26,035 | SEC |
| 2026-05-07 2026-05-08 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 3 | US$154.61 | US$463.83 | 9 | SEC |
| 2026-05-07 2026-05-08 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 428 | US$153.56 | US$65,723.68 | 12 | SEC |
| 2026-05-07 2026-05-08 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 9 | US$155.25 | US$1,397.25 | 0 | SEC |
| 2026-05-07 2026-05-08 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 226 | US$152.45 | US$34,453.70 | 440 | SEC |
| 2026-05-06 2026-05-07 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 240 | US$154.41 | US$37,058.40 | 866 | SEC |
| 2026-05-06 2026-05-07 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 100 | US$155.97 | US$15,597.00 | 766 | SEC |
| 2026-05-06 2026-05-07 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 8 | US$151.57 | US$1,212.56 | 1,658 | SEC |
| 2026-05-06 2026-05-07 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 424 | US$152.67 | US$64,732.08 | 1,234 | SEC |
| 2026-05-06 2026-05-07 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 128 | US$153.42 | US$19,637.76 | 1,106 | SEC |
| 2026-05-06 2026-05-07 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 100 | US$156.00 | US$15,600.00 | 666 | SEC |
| 2026-05-05 2026-05-06 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 68 | US$158.11 | US$10,751.48 | 1,666 | SEC |
| 2026-05-05 2026-05-06 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 155 | US$157.29 | US$24,379.95 | 1,734 | SEC |
| 2026-05-05 2026-05-06 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 173 | US$155.48 | US$26,898.04 | 2,010 | SEC |
| 2026-05-05 2026-05-06 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 363 | US$154.44 | US$56,061.72 | 2,183 | SEC |
| 2026-05-05 2026-05-06 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 120 | US$153.92 | US$18,470.40 | 2,546 | SEC |
| 2026-05-05 2026-05-06 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 121 | US$156.53 | US$18,940.13 | 1,889 | SEC |
| 2026-05-04 2026-05-05 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 172 | US$157.49 | US$27,088.28 | 2,666 | SEC |
| 2026-05-04 2026-05-05 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 235 | US$156.57 | US$36,793.95 | 2,838 | SEC |
| 2026-05-04 2026-05-05 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 325 | US$155.21 | US$50,443.25 | 3,073 | SEC |
| 2026-05-04 2026-05-05 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 236 | US$154.24 | US$36,400.64 | 3,398 | SEC |
| 2026-05-04 2026-05-05 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 32 | US$153.50 | US$4,912.00 | 3,634 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 288 | US$154.38 | US$44,461.44 | 4,326 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 346 | US$155.48 | US$53,796.08 | 3,980 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 52 | US$153.89 | US$8,002.28 | 4,614 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 82 | US$156.24 | US$12,811.68 | 3,898 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 106 | US$157.45 | US$16,689.70 | 3,792 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 65 | US$158.35 | US$10,292.75 | 3,727 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 38 | US$159.08 | US$6,045.04 | 3,689 | SEC |
| 2026-05-01 2026-05-04 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 23 | US$160.00 | US$3,680.00 | 3,666 | SEC |
| 2026-04-30 2026-05-01 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 101 | US$158.15 | US$15,973.15 | 4,666 | SEC |
| 2026-04-30 2026-05-01 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 42 | US$155.68 | US$6,538.56 | 5,624 | SEC |
| 2026-04-30 2026-05-01 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 340 | US$157.37 | US$53,505.80 | 4,767 | SEC |
| 2026-04-30 2026-05-01 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 517 | US$156.59 | US$80,957.03 | 5,107 | SEC |
| 2026-04-29 2026-04-30 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 102 | US$157.39 | US$16,053.78 | 5,688 | SEC |
| 2026-04-29 2026-04-30 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 339 | US$156.43 | US$53,029.77 | 5,790 | SEC |
| 2026-04-29 2026-04-30 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 259 | US$155.52 | US$40,279.68 | 6,129 | SEC |
| 2026-04-29 2026-04-30 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 278 | US$154.58 | US$42,973.24 | 6,388 | SEC |
| 2026-04-29 2026-04-30 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 22 | US$158.19 | US$3,480.18 | 5,666 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 380 | US$159.42 | US$60,579.60 | 6,929 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 62 | US$158.71 | US$9,840.02 | 7,309 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 120 | US$160.27 | US$19,232.40 | 6,809 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 8 | US$155.36 | US$1,242.88 | 7,646 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 53 | US$156.61 | US$8,300.33 | 7,593 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 222 | US$157.49 | US$34,962.78 | 7,371 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 54 | US$162.14 | US$8,755.56 | 6,666 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 89 | US$161.72 | US$14,393.08 | 6,720 | SEC |
| 2026-04-28 2026-04-29 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 12 | US$154.65 | US$1,855.80 | 7,654 | SEC |
| 2026-04-27 2026-04-28 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 409 | US$163.56 | US$66,896.04 | 7,702 | SEC |
| 2026-04-27 2026-04-28 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 280 | US$161.62 | US$45,253.60 | 8,342 | SEC |
| 2026-04-27 2026-04-28 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 231 | US$162.38 | US$37,509.78 | 8,111 | SEC |
| 2026-04-27 2026-04-28 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 36 | US$164.07 | US$5,906.52 | 7,666 | SEC |
| 2026-04-27 2026-04-28 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 44 | US$160.83 | US$7,076.52 | 8,622 | SEC |
| 2026-04-24 2026-04-27 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 74 | US$157.86 | US$11,681.64 | 9,592 | SEC |
| 2026-04-24 2026-04-27 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 190 | US$158.65 | US$30,143.50 | 9,402 | SEC |
| 2026-04-24 2026-04-27 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 375 | US$159.46 | US$59,797.50 | 9,027 | SEC |
| 2026-04-24 2026-04-27 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 330 | US$160.40 | US$52,932.00 | 8,697 | SEC |
| 2026-04-24 2026-04-27 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 28 | US$161.22 | US$4,514.16 | 8,669 | SEC |
| 2026-04-24 2026-04-27 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 3 | US$162.53 | US$487.59 | 8,666 | SEC |
| 2026-04-23 2026-04-24 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 21 | US$169.56 | US$3,560.76 | 9,666 | SEC |
| 2026-04-23 2026-04-24 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 373 | US$167.37 | US$62,429.01 | 9,741 | SEC |
| 2026-04-23 2026-04-24 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 127 | US$166.56 | US$21,153.12 | 10,114 | SEC |
| 2026-04-23 2026-04-24 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 158 | US$165.38 | US$26,130.04 | 10,241 | SEC |
| 2026-04-23 2026-04-24 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 267 | US$164.47 | US$43,913.49 | 10,399 | SEC |
| 2026-04-23 2026-04-24 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 54 | US$168.43 | US$9,095.22 | 9,687 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 75 | US$170.58 | US$12,793.50 | 11,193 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 249 | US$172.49 | US$42,950.01 | 10,687 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 21 | US$173.04 | US$3,633.84 | 10,666 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 105 | US$169.52 | US$17,799.60 | 11,268 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 101 | US$168.64 | US$17,032.64 | 11,373 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 141 | US$167.42 | US$23,606.22 | 11,474 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 20 | US$166.32 | US$3,326.40 | 11,615 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 31 | US$165.70 | US$5,136.70 | 11,635 | SEC |
| 2026-04-22 2026-04-23 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 257 | US$171.62 | US$44,106.34 | 10,936 | SEC |
| 2026-04-21 2026-04-22 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 214 | US$167.34 | US$35,810.76 | 11,666 | SEC |
| 2026-04-21 2026-04-22 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 332 | US$165.49 | US$54,942.68 | 12,192 | SEC |
| 2026-04-21 2026-04-22 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 78 | US$164.60 | US$12,838.80 | 12,524 | SEC |
| 2026-04-21 2026-04-22 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 64 | US$163.49 | US$10,463.36 | 12,602 | SEC |
| 2026-04-21 2026-04-22 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 312 | US$166.49 | US$51,944.88 | 11,880 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 284 | US$162.76 | US$46,223.84 | 13,382 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 524 | US$163.52 | US$85,684.48 | 12,858 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 124 | US$164.40 | US$20,385.60 | 12,734 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 9 | US$168.35 | US$1,515.15 | 12,666 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 3 | US$166.91 | US$500.73 | 12,691 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 16 | US$167.17 | US$2,674.72 | 12,675 | SEC |
| 2026-04-20 2026-04-21 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 40 | US$165.29 | US$6,611.60 | 12,694 | SEC |
| 2026-04-17 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 200 | US$163.33 | US$32,666.00 | 13,666 | SEC |
| 2026-04-17 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 216 | US$162.48 | US$35,095.68 | 13,866 | SEC |
| 2026-04-17 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 274 | US$161.41 | US$44,226.34 | 14,082 | SEC |
| 2026-04-17 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 226 | US$160.55 | US$36,284.30 | 14,356 | SEC |
| 2026-04-17 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 52 | US$159.38 | US$8,287.76 | 14,582 | SEC |
| 2026-04-17 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 32 | US$158.46 | US$5,070.72 | 14,634 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 36 | US$163.21 | US$5,875.56 | 14,678 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 76 | US$162.26 | US$12,331.76 | 14,714 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 240 | US$161.61 | US$38,786.40 | 14,790 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 201 | US$160.35 | US$32,230.35 | 15,030 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 219 | US$159.81 | US$34,998.39 | 15,231 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 216 | US$158.28 | US$34,188.48 | 15,450 | SEC |
| 2026-04-16 2026-04-20 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 12 | US$164.12 | US$1,969.44 | 14,666 | SEC |
| 2026-04-15 2026-04-16 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 383 | US$167.58 | US$64,183.14 | 16,283 | SEC |
| 2026-04-15 2026-04-16 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 537 | US$168.64 | US$90,559.68 | 15,746 | SEC |
| 2026-04-15 2026-04-16 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 68 | US$169.15 | US$11,502.20 | 15,678 | SEC |
| 2026-04-15 2026-04-16 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 8 | US$170.77 | US$1,366.16 | 15,670 | SEC |
| 2026-04-15 2026-04-16 | BLTE BELITE BIO, INC | MATA NATHAN L. Officer · Chief Scientific Officer | 卖出（S） | 4 | US$171.19 | US$684.76 | 15,666 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Chuang Hao-Yuan Director,Officer · Chief Financial Officer | 卖出（S） | 1,909 | US$182.58 | US$348,545.22 | 94,091 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Chuang Hao-Yuan Director,Officer · Chief Financial Officer | 卖出（S） | 2,000 | US$180.35 | US$360,700.00 | 98,000 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Chuang Hao-Yuan Director,Officer · Chief Financial Officer | 卖出（S） | 2,000 | US$181.40 | US$362,800.00 | 96,000 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Chuang Hao-Yuan Director,Officer · Chief Financial Officer | 卖出（S） | 291 | US$183.08 | US$53,276.28 | 93,800 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Chen Wan-Shan Director | 卖出（S） | 1,100 | US$180.43 | US$198,473.00 | 9,096 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Lin Yu-Hsin Director,Officer · Chief Executive Officer | 卖出（S） | 200 | US$183.00 | US$36,600.00 | 170,934 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Lin Yu-Hsin Director,Officer · Chief Executive Officer | 卖出（S） | 3,500 | US$181.33 | US$634,655.00 | 174,134 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Lin Yu-Hsin Director,Officer · Chief Executive Officer | 卖出（S） | 2,500 | US$180.36 | US$450,900.00 | 177,634 | SEC |
| 2026-04-09 2026-04-13 | BLTE BELITE BIO, INC | Lin Yu-Hsin Director,Officer · Chief Executive Officer | 卖出（S） | 3,000 | US$182.40 | US$547,200.00 | 171,134 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BLTE | 39,846.0578 | 50 | 63,379.3343 | 62.87% | B, Q, N |